Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Bourdeau

Showing results (101-110 of 121) with videos related to

Pageof 13
Sort By:
Anticancer Research|October 26, 2022
Hispanic <i>vs.</i> Caucasian Race/Ethnicity in Adrenocortical Carcinoma PatientsAndrea Panunzio, Stefano Tappero, Cristina Cano Garcia, et al.
Journal of Surgical Oncology|November 26, 2022
Contemporary conditional cancer-specific survival rates in surgically treated adrenocortical carcinoma patients: A stage-specific analysisAndrea Panunzio, Francesco Barletta, Stefano Tappero, et al.
Minerva Urology and Nephrology|August 2, 2023
Regional differences in stage distribution and rates of treatment for adrenocortical carcinoma across United States SEER registriesAndrea Panunzio, Stefano Tappero, Mattia Piccinelli, et al.
Nature Communications|April 23, 2024
The gut microbiome-prostate cancer crosstalk is modulated by dietary polyunsaturated long-chain fatty acidsGabriel Lachance, Karine Robitaille, Jalal Laaraj, et al.
European Journal of Endocrinology|November 4, 2011
Combined expression of BUB1B, DLGAP5, and PINK1 as predictors of poor outcome in adrenocortical tumors: validation in a Brazilian cohort of adult and pediatric patientsMaria Candida B V Fragoso, Madson Queiroz Almeida, Tania L Mazzuco, et al.
The Journal of Clinical Endocrinology and Metabolism|April 9, 2014
ARMC5 mutations are a frequent cause of primary macronodular adrenal HyperplasiaGuilherme Asmar Alencar, Antonio Marcondes Lerario, Mirian Yumie Nishi, et al.
Function (Oxford, England)|February 13, 2023
Comparing Transgenic Production to Supplementation of ω-3 PUFA Reveals Distinct But Overlapping Mechanisms Underlying Protection Against Metabolic and Hepatic DisordersNoëmie Daniel, Mélanie Le Barz, Patricia L Mitchell, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|December 31, 2022
University of Montreal's Clinician-Investigator Program: A 10-Year Descriptive EvaluationSamuel Mailhot-Larouche, Vincent Chauvette, David Bergeron, et al.
Human Molecular Genetics|December 17, 2013
Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomasLuis Jaime Castro-Vega, Alexandre Buffet, Aguirre A De Cubas, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 2021
Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' SurvivalVictor Srougi, Irina Bancos, Marilyne Daher, et al.
Pageof 13

Showing results (101-110 of 121) with videos related to

Sort By:
Pageof 13
Anticancer Research|October 26, 2022
Hispanic <i>vs.</i> Caucasian Race/Ethnicity in Adrenocortical Carcinoma PatientsAndrea Panunzio, Stefano Tappero, Cristina Cano Garcia, et al.
Journal of Surgical Oncology|November 26, 2022
Contemporary conditional cancer-specific survival rates in surgically treated adrenocortical carcinoma patients: A stage-specific analysisAndrea Panunzio, Francesco Barletta, Stefano Tappero, et al.
Minerva Urology and Nephrology|August 2, 2023
Regional differences in stage distribution and rates of treatment for adrenocortical carcinoma across United States SEER registriesAndrea Panunzio, Stefano Tappero, Mattia Piccinelli, et al.
Nature Communications|April 23, 2024
The gut microbiome-prostate cancer crosstalk is modulated by dietary polyunsaturated long-chain fatty acidsGabriel Lachance, Karine Robitaille, Jalal Laaraj, et al.
European Journal of Endocrinology|November 4, 2011
Combined expression of BUB1B, DLGAP5, and PINK1 as predictors of poor outcome in adrenocortical tumors: validation in a Brazilian cohort of adult and pediatric patientsMaria Candida B V Fragoso, Madson Queiroz Almeida, Tania L Mazzuco, et al.
The Journal of Clinical Endocrinology and Metabolism|April 9, 2014
ARMC5 mutations are a frequent cause of primary macronodular adrenal HyperplasiaGuilherme Asmar Alencar, Antonio Marcondes Lerario, Mirian Yumie Nishi, et al.
Function (Oxford, England)|February 13, 2023
Comparing Transgenic Production to Supplementation of ω-3 PUFA Reveals Distinct But Overlapping Mechanisms Underlying Protection Against Metabolic and Hepatic DisordersNoëmie Daniel, Mélanie Le Barz, Patricia L Mitchell, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|December 31, 2022
University of Montreal's Clinician-Investigator Program: A 10-Year Descriptive EvaluationSamuel Mailhot-Larouche, Vincent Chauvette, David Bergeron, et al.
Human Molecular Genetics|December 17, 2013
Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomasLuis Jaime Castro-Vega, Alexandre Buffet, Aguirre A De Cubas, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 2021
Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' SurvivalVictor Srougi, Irina Bancos, Marilyne Daher, et al.
Pageof 13